This randomized clinical trial investigates the long-term efficacy of mavacamten in reducing the need for septal reduction therapy in patients with obstructive hypertrophic cardiomyopathy.
AbstractBackgroundObesity is a known risk factor for heart failure with preserved ejection fraction (HFpEF) and is considered a distinct phenotype with more concentric remodeling. Epicardial…
Heart disease was once considered a man’s disease. Dr. Nanette Wenger changed that. But the 93-year-old cardiologist says her work is not yet done.
This randomized clinical trial assesses the effect of muvalaplin on lipoprotein(a) concentrations in patients with high baseline lipoprotein(a) levels and cardiovascular risk factors.
Request permissions for this article. Kaiser Permanente San Francisco Medical Center, San Francisco, CA; Kaiser Permanente Northern California (KPNC) Division of Research, Pleasanton, CA Cone…
This cohort study examines the association of treatment with metformin and add-on antidiabetic medications with asthma attacks.
Rigorous, dependable research has always been at the core of the American Heart Association (AHA) mission to be a relentless force for a world of…
BACKGROUND: Preeclampsia poses a substantial clinical challenge, characterized by maternal hypertension, cardiac dysfunction, and persistent cardiovascular risks for both the mother and offspring. Despite the…
Citing a “crisis” in healthcare, nearly 400 primary care physicians at Massachusetts General Hospital and Brigham & Women’s Hospital are taking steps to unionize, a…
Quote shared via Kindle: “Nassim Taleb explained: “True success is exiting some rat race to modulate one’s activities for peace of mind.”…
Podcast Episode · Heart Corner: Innovations in Cardiovascular Science · 11/18/2024 · 20m
